The reaffirmation of a Buy rating and a $20 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short-term impact on ATAI Life Sciences' stock price. Analyst ratings, especially those that are maintained or upgraded, tend to influence investor sentiment and can result in stock price movements.